Ki-67 antigen in ameloblastomas: correlation with clinical and histological parameters in 54 cases from Kenya
Authors:
- Alan T. CruchleyACAlan T. Cruchley
- Gareth L. HowellsGHGareth L. Howells
- David M. WilliamsDWDavid M. Williams
- 1 October 1997
- journal article
- Published by Elsevier in International Journal of Oral and Maxillofacial Surgery
- Vol. 26 (5) , 376-379
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Expression of proliferating cell nuclear antigen (PCNA) and Ki‐67 in unicystic ameloblastomaHistopathology, 1995
- Immunohistochemical study on proliferating cell nuclear antigen expression in ameloblastomasOral Oncology, 1994
- Ameloblastoma: clinical features and management of 315 cases from Kaduna, NigeriaJournal of Cranio-Maxillofacial Surgery, 1993
- The relevance of antibody concentration to the immunohistological quantification of cell proliferation‐associated antigensHistopathology, 1993
- The complexities of proliferating cell nuclear antigenHistopathology, 1992
- Labeling index in squamous cell carcinoma of the larynxHead & Neck, 1991
- Monoclonal antibody Ki‐67: its use in histopathologyHistopathology, 1990
- The labelling index: a prognostic factor in head and neck carcinomaRadiotherapy and Oncology, 1989
- Prognostic evaluation of ameloblastoma based on histologic and radiographic typingJournal of Oral and Maxillofacial Surgery, 1989
- Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationInternational Journal of Cancer, 1983